FDA.reportPublic FDA data

0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]

RxCUI
1986830
RxNorm name
0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]
Display name
0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]
Full name
0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125614ShingrixZoster Vaccine Recombinant, Adjuvanted351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
0280849d-5c78-4a9d-8941-4eab429f6bd80.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]SBD23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
0280849d-5c78-4a9d-8941-4eab429f6bd8SHINGRIX vaccine 0.5 ML InjectionPSN23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
0280849d-5c78-4a9d-8941-4eab429f6bd80.5 ML Shingrix 0.1 MG/ML InjectionSY23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
0280849d-5c78-4a9d-8941-4eab429f6bd8Shingrix vaccine 0.5 ML InjectionSY23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
279a251c-f4d0-4c47-b999-7ef1a45ac0d00.5 ML Shingrix 0.1 MG/ML InjectionSY6These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720240109
279a251c-f4d0-4c47-b999-7ef1a45ac0d0SHINGRIX vaccine 0.5 ML InjectionPSN6These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720240109
279a251c-f4d0-4c47-b999-7ef1a45ac0d00.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]SBD6These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720240109
279a251c-f4d0-4c47-b999-7ef1a45ac0d0Shingrix vaccine 0.5 ML InjectionSY6These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720240109
e9ba0102-8cbb-4c4c-810e-292119095a8a0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]SBD2These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720210415
e9ba0102-8cbb-4c4c-810e-292119095a8a0.5 ML Shingrix 0.1 MG/ML InjectionSY2These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720210415
e9ba0102-8cbb-4c4c-810e-292119095a8aSHINGRIX vaccine 0.5 ML InjectionPSN2These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720210415
e9ba0102-8cbb-4c4c-810e-292119095a8aShingrix vaccine 0.5 ML InjectionSY2These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720210415